VERO
Venus Concept, Inc.
NASDAQ · Healthcare · Medical - Devices · CA
$0.31
+2.64%Year over year
Reported trailing growth
- Revenue
- -12.4%
- EBITDA
- -21.1%
- EBIT
- -23.4%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -15.0%
- EBITDA
- -38.0%
- EBIT
- +4.0%
- Net income
- -26.2%
- EPS
- —
- Free cash flow
- +13.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2025